Welcome!

News Feed Item

FONAR Announces Fiscal 2014 Second Quarter Earnings Results

MELVILLE, NY -- (Marketwired) -- 02/14/14 -- FONAR Corporation (NASDAQ: FONR),

  • Second Fiscal 2014 Quarter Net Revenues increase 83% over Second Fiscal Quarter 2013 to $17.6 million.
  • Second Fiscal 2014 Quarter Net Income increases 88% over Second Fiscal Quarter 2013 to $3.0 million
  • Diluted EPS Available to Common Stockholders for the Second Fiscal 2014 Quarter was $0.33, an increase of 57% over Second Fiscal Quarter 2013
  • FONAR records Fifthteenth straight quarter of positive Net Income and Income from Operations of which most recent ten were greater than $1.5 Million

FONAR Corporation (NASDAQ: FONR), The Inventor of MR Scanning™, reported its second quarter, fiscal 2014 results for the quarter ended December 31, 2013. The Company's two industry segments include the management of 23 Stand-Up® MRI (UPRIGHT® MRI) centers as well as its traditional MRI development, manufacturing and service business. Its stellar product line includes the FONAR UPRIGHT® Multi-Position™ MRI (aka STAND-UP® MRI which enables full weight-bearing MRI imaging and is particularly powerful in the gravity sensitive regions of the human anatomy, e.g. the spine, brain, hip, knee, ankle, foot, shoulder, and pelvis. The FONAR UPRIGHT® Multi-Position™ MRI scanner is the world's only MRI scanner licensed under FONAR's multiple UPRIGHT® MRI patents to scan all the patient's body parts in their normal fully weight-bearing UPRIGHT® position.

Statement of Operations Items

Income from operations for the quarter ended December 31, 2013, increased 91% to $3.3 million, as compared to $1.7 million for the same period one year earlier. For the six month period ended December 31, 2013, income from operations was $7.4 million as compared to $3.6 million during the corresponding period one year earlier, an increase of 104%.

Net Income for the quarter ended December 31, 2013, increased 88% to $3.0 million, as compared to $1.6 million for the same period one year earlier. For the six month period ended December 31, 2013, net income was $6.7 million as compared to $3.4 million during the corresponding period one year earlier, an increase of 96%.

Diluted Net Income per Common Share available to Common shareholders for the quarter ended December 31, 2013 increased 57% to $0.33, as compared to $0.21 for the same period one year earlier.

For the six month period ended December 31, 2013, Diluted Net Income per Common Share available to Common shareholders increased 63% to $0.70, as compared to $0.43 for the same period one year earlier.

Total revenues for the quarter ended December 31, 2013, increased 83% to $17.6 million as compared to $9.6 million during the same period one year earlier. For the six month period ended December 31, 2013, total revenues increased 80% to $34.4 million as compared to $19.1 million, one year earlier.

Revenue from the patient fee segment and management and other fees segment, for the quarter ended December 31, 2013, increased 149% to $14.3 million, as compared to $5.7 million during the same period one year earlier. At six months this also increased 149% to $28.5 million as compared to the same period one year earlier at $11.5 million. This is the revenue that comes from patient fees and the management of the 23 FONAR Stand-Up™ MRI diagnostic imaging centers, by FONAR's HMCA subsidiary.

Balance Sheet Items

At December 31, 2013, total current assets were $43.5 million, total assets were $77.1 million, total current liabilities were $23.2 million, and total long-term liabilities were $11.8 million.

At December 31, 2013, total cash and cash equivalents were $9.4 million.

At December 31, 2013, total stockholder's equity was $42.1 million.

See the accompanying tables for more details.

Recent Significant Events

In December, 2013, the Company settled a two-year old patent infringement case brought against it. The infringement action alleged that FONAR's Upright® MRI scanners infringe plaintiff's patent which relates to the moving of a patient into the scanner. The Company took the position that the plaintiff's claims were without merit and that their patent was invalid. The parties have settled the case and while FONAR will pay $150,000, there are certain licenses and covenants not to sue again.

Management Discussion

The acquisition of Health Diagnostic Management (HDM) has been a significant source of profitability for the Company. The diluted earnings per share available for the common stockholder for the six months which ended on December 31, 2013 increased 63% to $0.70 when compared to one year earlier. The Company plans to continue to grow at a reasonable pace while maintaining its highly profitable profile."

About FONAR

FONAR (NASDAQ: FONR), Melville, NY, The Inventor of MR Scanning™, was incorporated in 1978, and is the first, oldest and most experienced MRI company in the industry. FONAR introduced the world's first commercial MRI in 1980, and went public in 1981. Since its inception, nearly 300 recumbent-OPEN MRIs and 157 UPRIGHT® Multi-Position™ MRI scanners have been installed worldwide. FONAR's stellar product is the UPRIGHT® MRI (also known as the Stand-Up® MRI), the only whole-body MRI that performs Position™ imaging (pMRI™) and scans patients in numerous weight-bearing positions, i.e. standing, sitting, in flexion and extension, as well as the conventional lie-down position. The FONAR UPRIGHT® MRI often sees the patient's problem that other scanners cannot because they are lie-down and "weightless" only scanners. The patient-friendly UPRIGHT® MRI has a near-zero claustrophobic rejection rate by patients. As a FONAR customer states, "If the patient is claustrophobic in this scanner, they'll be claustrophobic in my parking lot." Approximately 85% of patients are scanned sitting while they watch a 42" flat screen TV. FONAR is headquartered on Long Island, New York.

UPRIGHT® and STAND-UP® are registered trademarks and The Inventor of MR Scanning™, Full Range of Motion™, Multi-Position™, Upright Radiology™, The Proof is in the Picture™, True Flow™, pMRI™, Spondylography™, Dynamic™,Spondylometry™, CSP™, and Landscape™, are trademarks of FONAR Corporation.

This release may include forward-looking statements from the company that may or may not materialize. Additional information on factors that could potentially affect the company's financial results may be found in the company's filings with the Securities and Exchange Commission.



                     FONAR CORPORATION AND SUBSIDIARIES
                    CONDENSED CONSOLIDATED BALANCE SHEETS
         (AMOUNTS AND SHARES IN THOUSANDS,EXCEPT PER SHARE AMOUNTS)
                                 (UNAUDITED)

                                   ASSETS

                                                 December 31,     June 30,
ASSETS                                                2013          2013
                                                 ------------- -------------
Cash and cash equivalents                        $       9,425 $       7,871
Accounts receivable - net                                5,359         4,444
Accounts receivable - related party                         60             -
Medical receivable - net                                 8,884         8,126
Management and other fees receivable - net              12,347        11,466
Management and other fees receivable - related
 medical practices - net                                 2,985         2,382
Inventories                                              2,562         2,077
Prepaid expenses and other current assets                1,901         1,500
                                                 ------------- -------------
Total Current Assets                                    43,523        37,866

Property and equipment - net                            16,538        17,524
Goodwill                                                 1,767         1,767
Other intangible assets - net                           11,271        11,904
Deferred income tax asset                                2,936         2,936
Other assets                                             1,050         1,154
                                                 ------------- -------------
Total Assets                                     $      77,085 $      73,151
                                                 ============= =============

                    LIABILITIES AND STOCKHOLDERS' EQUITY

                                                 December 31,    June 30,
LIABILITIES                                           2013          2013
                                                 ------------- -------------
Current Liabilities:
  Current portion of long-term debt and capital
   leases                                        $       3,048 $       2,886
  Accounts payable                                       2,941         2,752
  Other current liabilities                              9,401         8,636
  Unearned revenue on service contracts                  5,725         4,965
  Unearned revenue on service contracts -
   related party                                            55             -
  Customer advances                                      2,041         1,858
  Income tax payable                                         -            20
                                                 ------------- -------------
    Total Current Liabilities                           23,211        21,117

Long-Term Liabilities:
  Due to related medical practices                         229           231
  Long-term debt and capital leases, less
   current portion                                      10,530        12,887
  Deferred income tax liability                            462           462
  Other liabilities                                        596           654
                                                 ------------- -------------
    Total Long-Term Liabilities                         11,817        14,234
                                                 ------------- -------------
    Total Liabilities                                   35,028        35,351
                                                 ------------- -------------



                     FONAR CORPORATION AND SUBSIDIARIES
                   CONDENSED CONSOLIDATED BALANCE SHEETS
         (AMOUNTS AND SHARES IN THOUSANDS,EXCEPT PER SHARE AMOUNTS)
                                (UNAUDITED)

              LIABILITIES AND STOCKHOLDERS' EQUITY (Continued)

                                                 December 31,    June 30,
STOCKHOLDERS' EQUITY:                                2013          2013
                                                 ------------  ------------
Class A non-voting preferred stock $.0001 par
 value; 453 shares authorized at December 31,
 2013 and June 30, 2013, 313 issued and
 outstanding at December 31, 2013 and June 30,
 2013                                                       -             -
Preferred stock $.001 par value; 567 shares
 authorized at December 31, 2013 and June 30,
 2013, issued and outstanding - none                        -             -
Common Stock $.0001 par value; 8,500 shares
 authorized at December 31, 2013 and June 30,
 2013, 6,022 and 5,981 issued at December 31,
 2013 and June 30, 2013, respectively; 6,010 and
 5,969 outstanding at December 31, 2013 and June
 30, 2013, respectively                                     1             1
Class B Common Stock (10 votes per share) $
 .0001 par value; 227 shares authorized at
 December 31, 2013 and June 30, 2013, .146
 issued and outstanding at December 31, 2013 and
 June 30, 2013                                              -             -
Class C Common Stock (25 votes per share) $.0001
 par value; 567 shares authorized at December
 31, 2013 and June 30, 2013, 383 issued and
 outstanding at December 31, 2013 and June 30,
 2013                                                       -             -
Paid-in capital in excess of par value                174,770       174,499
Accumulated deficit                                  (155,075)     (159,655)
Notes receivable from employee stockholders               (42)          (55)
Treasury stock, at cost - 12 shares of common
 stock at December 31, 2013 and June 30, 2013            (675)         (675)
                                                 ------------  ------------
Total Fonar Corporation Stockholder Equity             18,979        14,115
Non controlling interests                              23,078        23,685
                                                 ------------  ------------

Total Stockholders' Equity                             42,057        37,800
                                                 ------------  ------------

Total Liabilities and Stockholders' Equity       $     77,085  $     73,151
                                                 ============  ============



                     FONAR CORPORATION AND SUBSIDIARIES
                CONDENSED CONSOLIDATED STATEMENTS OF INCOME
         (AMOUNTS AND SHARES IN THOUSANDS,EXCEPT PER SHARE AMOUNTS)
                                (UNAUDITED)

                                                 FOR THE THREE MONTHS ENDED
                                                        DECEMBER 31,
                                                 --------------------------
REVENUES                                             2013          2012
                                                 ------------  ------------
  Product sales - net                            $        755  $      1,080
  Service and repair fees - net                         2,548         2,765
  Service and repair fees - related parties -
   net                                                     28            28
  Patient fee revenue, net of contractual
   allowances and discounts                             5,894             -
  Provision for bad debts for patient fee              (2,223)            -
  Management and other fees - net                       8,274         3,775
  Management and other fees - related medical
   practices - net                                      2,333         1,965
                                                 ------------  ------------
    Total Revenues - Net                               17,609         9,613
                                                 ------------  ------------

COSTS AND EXPENSES
  Costs related to product sales                          631           904
  Costs related to service and repair fees                587           894
  Costs related to service and repair fees -
   related parties                                          6             9
  Costs related to patient fee revenue                  2,028             -
  Costs related to management and other fees            5,190         2,235
  Costs related to management and other fees -
   related medical practices                            1,270           852
  Research and development                                374           320
  Selling, general and administrative                   4,352         2,352
  Provision for bad debts                                (124)          325
                                                 ------------  ------------
    Total Costs and Expenses                           14,314         7,891
                                                 ------------  ------------
Income From Operations                                  3,295         1,722
Interest Expense                                         (237)         (103)
Investment Income                                          60            60
Other Expense                                               -            (4)
                                                 ------------  ------------
Income Before Provision for Income Taxes and Non
 Controlling Interests                                  3,118         1,675
Provision for Income Taxes                                 70            55
                                                 ------------  ------------
Net Income                                              3,048         1,620
Net Income - Non Controlling Interests                   (905)         (271)
                                                 ------------  ------------
Net Income - Controlling Interests               $      2,143  $      1,349
                                                 ============  ============
Net Income Available to Common Stockholders      $      2,003  $      1,259
                                                 ============  ============
Net Income Available to Class A Non-Voting
 Preferred Stockholders                          $        104  $         67
                                                 ============  ============
Net Income Available to Class C Common
 Stockholders                                    $         36  $         23
                                                 ============  ============
Basic Net Income Per Common Share Available to
 Common Stockholders                             $       0.33  $       0.21
                                                 ============  ============
Diluted Net Income Per Common Share Available to
 Common Stockholders                             $       0.33  $       0.21
                                                 ============  ============
Basic and Diluted Income Per Share-Common C      $       0.09  $       0.06
                                                 ============  ============
Weighted Average Basis Shares Outstanding-Common
 Stockholders                                           6,006         5,926
                                                 ============  ============
Weighted Average Diluted Shares Outstanding             6,133         6,054
                                                 ============  ============
Weighted Average Basic Shares Outstanding -
 Class C                                                  383           383
                                                 ============  ============
Weighted Average Diluted Shares Outstanding -
 Class C Common                                           383           383
                                                 ============  ============



                     FONAR CORPORATION AND SUBSIDIARIES
                CONDENSED CONSOLIDATED STATEMENTS OF INCOME
        (AMOUNTS AND SHARES IN THOUSANDS, EXCEPT PER SHARE AMOUNTS)
                                (UNAUDITED)

                                                  FOR THE SIX MONTHS ENDED
                                                        DECEMBER 31,
                                                 --------------------------
                                                     2013          2012
                                                 ------------  ------------
REVENUES
  Product sales - net                            $        783  $      2,121
  Service and repair fees - net                         5,060         5,474
  Service and repair fees - related parties -
   net                                                     55            55
  Patient fee revenue, net of contractual
   allowances and discounts                            11,721             -
  Provision for bad debts for patient fee              (4,262)            -
  Management and other fees - net                      16,417         7,544
  Management and other fees - related medical
   practices - net                                      4,666         3,930
                                                 ------------  ------------
    Total Revenues - Net                               34,440        19,124
                                                 ------------  ------------

COSTS AND EXPENSES
  Costs related to product sales                          678         1,959
  Costs related to service and repair fees              1,131         1,760
  Costs related to service and repair fees -
   related parties                                         12            18
  Costs related to patient fee revenue                  3,877             -
  Costs related to management and other fees           10,264         4,406
  Costs related to management and other fees -
   related medical practices                            2,490         1,669
  Research and development                                769           650
  Selling, general and administrative                   8,089         4,564
  Provision for bad debts                                (218)          500
                                                 ------------  ------------
    Total Costs and Expenses                           27,092        15,526
                                                 ------------  ------------
Income From Operations                                  7,348         3,598
Interest Expense                                         (480)         (179)
Investment Income                                         121           120
Other Expense                                            (151)          (13)
                                                 ------------  ------------
Income Before Provision for Income Taxes and Non
 Controlling Interests                                  6,838         3,526
Provision for Income Taxes                                170           127
                                                 ------------  ------------
Net Income                                              6,668         3,399
Net Income - Non Controlling Interests                 (2,088)         (598)
                                                 ------------  ------------
Net Income - Controlling Interests               $      4,580  $      2,801
                                                 ============  ============
Net Income Available to Common Stockholders      $      4,280  $      2,616
                                                 ============  ============
Net Income Available to Class A Non-voting
 Preferred Stockholders                          $        223  $        138
                                                 ============  ============
Net Income Available to Class C Common
 Stockholders                                    $         77  $         47
                                                 ============  ============
Basic Net Income Per Common Share Available to
 Common Stockholders                             $       0.71  $       0.44
                                                 ============  ============
Diluted Net Income Per Common Share Available to
 Common Stockholders                             $       0.70  $       0.43
                                                 ============  ============
Basic and Diluted Income Per Share-Common C      $       0.20  $       0.12
                                                 ============  ============
Weighted Average Basic Shares Outstanding               5,992         5,914
                                                 ============  ============
Weighted Average Diluted Shares Outstanding             6,120         6,041
                                                 ============  ============
Weighted Average Basic Shares Outstanding -
 Class C Common                                           383           383
                                                 ============  ============
Weighted Average Diluted Shares Outstanding -
 Class C Common                                           383           383
                                                 ============  ============

Contact:
Daniel Culver
Director of Communications
E-mail: Email Contact
www.fonar.com

More Stories By Marketwired .

Copyright © 2009 Marketwired. All rights reserved. All the news releases provided by Marketwired are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited to, posting, emailing, faxing, archiving in a public database, redistributing via a computer network or in a printed form.

Latest Stories
SYS-CON Events announced today that HTBase will exhibit at SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. HTBase (Gartner 2016 Cool Vendor) delivers a Composable IT infrastructure solution architected for agility and increased efficiency. It turns compute, storage, and fabric into fluid pools of resources that are easily composed and re-composed to meet each application’s needs. With HTBase, companies can quickly prov...
Keeping pace with advancements in software delivery processes and tooling is taxing even for the most proficient organizations. Point tools, platforms, open source and the increasing adoption of private and public cloud services requires strong engineering rigor - all in the face of developer demands to use the tools of choice. As Agile has settled in as a mainstream practice, now DevOps has emerged as the next wave to improve software delivery speed and output. To make DevOps work, organization...
SYS-CON Events announced today that SoftLayer, an IBM Company, has been named “Gold Sponsor” of SYS-CON's 18th Cloud Expo, which will take place on June 7-9, 2016, at the Javits Center in New York, New York. SoftLayer, an IBM Company, provides cloud infrastructure as a service from a growing number of data centers and network points of presence around the world. SoftLayer’s customers range from Web startups to global enterprises.
China Unicom exhibit at the 19th International Cloud Expo, which took place at the Santa Clara Convention Center in Santa Clara, CA, in November 2016. China United Network Communications Group Co. Ltd ("China Unicom") was officially established in 2009 on the basis of the merger of former China Netcom and former China Unicom. China Unicom mainly operates a full range of telecommunications services including mobile broadband (GSM, WCDMA, LTE FDD, TD-LTE), fixed-line broadband, ICT, data communica...
Whether you like it or not, DevOps is on track for a remarkable alliance with security. The SEC didn’t approve the merger. And your boss hasn’t heard anything about it. Yet, this unruly triumvirate will soon dominate and deliver DevSecOps faster, cheaper, better, and on an unprecedented scale. In his session at DevOps Summit, Frank Bunger, VP of Customer Success at ScriptRock, discussed how this cathartic moment will propel the DevOps movement from such stuff as dreams are made on to a practic...
In their Live Hack” presentation at 17th Cloud Expo, Stephen Coty and Paul Fletcher, Chief Security Evangelists at Alert Logic, provided the audience with a chance to see a live demonstration of the common tools cyber attackers use to attack cloud and traditional IT systems. This “Live Hack” used open source attack tools that are free and available for download by anybody. Attendees learned where to find and how to operate these tools for the purpose of testing their own IT infrastructure. The...
SYS-CON Events announced today that CA Technologies has been named “Platinum Sponsor” of SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY, and the 21st International Cloud Expo®, which will take place October 31-November 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. CA Technologies helps customers succeed in a future where every business – from apparel to energy – is being rewritten by software. From ...
SYS-CON Events announced today that MobiDev, a client-oriented software development company, will exhibit at SYS-CON's 20th International Cloud Expo®, which will take place June 6-8, 2017, at the Javits Center in New York City, NY, and the 21st International Cloud Expo®, which will take place October 31-November 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. MobiDev is a software company that develops and delivers turn-key mobile apps, websites, web services, and complex softw...
SYS-CON Events announced today that Loom Systems will exhibit at SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. Founded in 2015, Loom Systems delivers an advanced AI solution to predict and prevent problems in the digital business. Loom stands alone in the industry as an AI analysis platform requiring no prior math knowledge from operators, leveraging the existing staff to succeed in the digital era. With offices in S...
SYS-CON Events announced today that Cloud Academy will exhibit at SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. Cloud Academy is the industry’s most innovative, vendor-neutral cloud technology training platform. Cloud Academy provides continuous learning solutions for individuals and enterprise teams for Amazon Web Services, Microsoft Azure, Google Cloud Platform, and the most popular cloud computing technologies. Ge...
Historically, some banking activities such as trading have been relying heavily on analytics and cutting edge algorithmic tools. The coming of age of powerful data analytics solutions combined with the development of intelligent algorithms have created new opportunities for financial institutions. In his session at 20th Cloud Expo, Sebastien Meunier, Head of Digital for North America at Chappuis Halder & Co., will discuss how these tools can be leveraged to develop a lasting competitive advanta...
"My role is working with customers, helping them go through this digital transformation. I spend a lot of time talking to banks, big industries, manufacturers working through how they are integrating and transforming their IT platforms and moving them forward," explained William Morrish, General Manager Product Sales at Interoute, in this SYS-CON.tv interview at 18th Cloud Expo, held June 7-9, 2016, at the Javits Center in New York City, NY.
For organizations that have amassed large sums of software complexity, taking a microservices approach is the first step toward DevOps and continuous improvement / development. Integrating system-level analysis with microservices makes it easier to change and add functionality to applications at any time without the increase of risk. Before you start big transformation projects or a cloud migration, make sure these changes won’t take down your entire organization.
With billions of sensors deployed worldwide, the amount of machine-generated data will soon exceed what our networks can handle. But consumers and businesses will expect seamless experiences and real-time responsiveness. What does this mean for IoT devices and the infrastructure that supports them? More of the data will need to be handled at - or closer to - the devices themselves.
DevOps is often described as a combination of technology and culture. Without both, DevOps isn't complete. However, applying the culture to outdated technology is a recipe for disaster; as response times grow and connections between teams are delayed by technology, the culture will die. A Nutanix Enterprise Cloud has many benefits that provide the needed base for a true DevOps paradigm.